Highlights on drug research and technology from my reading-
Stedesa may help lower seizure frequency in patients with epilepsy :
Proceeding published from American Neurological Association reported, "Eslicarbazepine acetate (Stedesa), a European anti-epileptic drug not yet licensed in the US, reduced seizure frequency and was well tolerated as an add-on treatment in patients with refractory partial-onset seizures in a trial reported".
Nortriptyline may be associated with increase in suicidal thoughts in men ?
There are press reports that state "the largest clinical trial to date comparing" nortriptyline, "an older, tricyclic antidepressant, with" escitalopram, "a newer antidepressant of the selective serotonin reuptake inhibitor (SSRI) class, find that the emergence of suicidal thinking was almost 10 times more common in men taking the older" medicine "than in those taking the newer medication."
Infliximab may be associated with lower colectomy rates in UC patients.
According to a research paper published in J.Gastroenterology, "Infliximab treatment is linked to lower colectomy rates in patients with moderate to severe active ulcerative colitis”.
Cystic Fibrosis patients appear to be taking wide variety of medication ?
Cystic fibrosis, a killer disease, like drowning on the inside ! Lead author Dr. Frank J. Accurso from University of Colorado researchers has found that "patients with cystic fibrosis are taking a wide variety of medication."
For details on this topic please visit- http://www.pharm-education.com/2009/11/drug-research-and-technology-update_09.html
Disclaimer : The above information has been cited from literature in public domain. This is for research purpose/ dissemination of knowledge only and should not be construed as medical advise.